Amylyx Pharmaceuticals Inc (AMLX)
NASDAQ:AMLX
US Market

Amylyx Pharmaceuticals Inc (AMLX) Income Statement

Compare
534 Followers

Amylyx Pharmaceuticals Inc Income Statement

Last quarter (Q4 2024), Amylyx Pharmaceuticals Inc's total revenue was $-665.00K, a decrease of -100.61% from the same quarter last year. In Q4, Amylyx Pharmaceuticals Inc's net income was $-37.55M. See Amylyx Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 87.37M$ 380.79M$ 22.23M$ 285.00K$ 650.00K
Gross Profit
$ 45.22M$ 355.35M$ 19.24M$ 233.00K$ -23.94M
Operating Expenses
$ 359.95M$ 316.54M$ 220.58M$ 82.69M$ 39.01M
Depreciation and Amortization
$ 904.00K$ 1.09M$ 487.00K$ 52.00K$ 1.00K
EBITDA
$ -290.98M$ 39.89M$ -200.85M$ -82.64M$ -39.00M
Operating Income
$ -314.73M$ 38.80M$ -201.34M$ -82.69M$ -39.01M
Other Income/Expenses
$ 12.60M$ 15.49M$ 3.74M$ -5.24M$ -3.27M
Pretax Income
$ -302.14M$ 54.30M$ -197.60M$ -87.93M$ -42.28M
Net Income
$ -301.74M$ 49.27M$ -198.38M$ -87.88M$ -44.84M
Per Share Metrics
Basic EPS
$ -4.43$ 0.73$ -2.98$ -1.52$ -0.79
Diluted EPS
$ -4.43$ 0.70$ -2.98$ -1.52$ -0.79
Weighted Average Shares Outstanding
68.14M 67.23M 66.51M 57.86M 56.47M
Weighted Average Shares Outstanding (Diluted)
68.14M 69.99M 66.51M 57.86M 56.47M
Currency in USD

Amylyx Pharmaceuticals Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis